IMAC Holdings, Inc. (BACK)
USD 0.04
(45.21%)
USD 0.04
(45.21%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.14 Million USD | -89.68% |
| 2022 | 11.08 Million USD | -59.3% |
| 2021 | 27.22 Million USD | 37.9% |
| 2020 | 19.74 Million USD | -3.29% |
| 2019 | 20.41 Million USD | 84.37% |
| 2018 | 11.07 Million USD | 765.84% |
| 2017 | 1.27 Million USD | -20.13% |
| 2016 | 1.6 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 910.84 Thousand USD | -20.39% |
| 2023 Q3 | 4.26 Million USD | -8.19% |
| 2023 Q4 | 1.14 Million USD | -73.17% |
| 2023 FY | 1.14 Million USD | -89.68% |
| 2023 Q1 | 5.84 Million USD | -47.27% |
| 2023 Q2 | 4.64 Million USD | -20.5% |
| 2022 Q2 | 22.06 Million USD | -8.81% |
| 2022 FY | 11.08 Million USD | -59.3% |
| 2022 Q3 | 18.53 Million USD | -16.02% |
| 2022 Q1 | 24.19 Million USD | -11.12% |
| 2022 Q4 | 11.08 Million USD | -40.2% |
| 2021 Q3 | 29.16 Million USD | -10.35% |
| 2021 FY | 27.22 Million USD | 37.9% |
| 2021 Q1 | 33.62 Million USD | 70.3% |
| 2021 Q4 | 27.22 Million USD | -6.63% |
| 2021 Q2 | 32.53 Million USD | -3.26% |
| 2020 Q4 | 19.74 Million USD | 1.92% |
| 2020 Q2 | 21.86 Million USD | 3.59% |
| 2020 Q1 | 21.1 Million USD | 3.36% |
| 2020 FY | 19.74 Million USD | -3.29% |
| 2020 Q3 | 19.37 Million USD | -11.37% |
| 2019 Q3 | 21.01 Million USD | -1.99% |
| 2019 Q4 | 20.41 Million USD | -2.85% |
| 2019 Q2 | 21.44 Million USD | 19.19% |
| 2019 Q1 | 17.99 Million USD | 62.44% |
| 2019 FY | 20.41 Million USD | 84.37% |
| 2018 Q2 | 10.92 Million USD | 238.87% |
| 2018 FY | 11.07 Million USD | 765.84% |
| 2018 Q4 | 11.07 Million USD | -3.31% |
| 2018 Q3 | 11.45 Million USD | 4.87% |
| 2018 Q1 | 3.22 Million USD | 151.99% |
| 2017 Q4 | 1.27 Million USD | 0.0% |
| 2017 FY | 1.27 Million USD | -20.13% |
| 2016 FY | 1.6 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 99.979% |
| Addus HomeCare Corporation | 1.02 Billion USD | 99.888% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | 99.464% |
| Amedisys, Inc. | 2.06 Billion USD | 99.944% |
| Astrana Health, Inc. | 933.36 Million USD | 99.877% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 99.93% |
| biote Corp. | 155.29 Million USD | 99.263% |
| Cryo-Cell International, Inc. | 61.22 Million USD | 98.131% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 99.832% |
| COMPASS Pathways plc | 275.98 Million USD | 99.585% |
| DocGo Inc. | 490.45 Million USD | 99.767% |
| The Ensign Group, Inc. | 4.17 Billion USD | 99.973% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 99.858% |
| InnovAge Holding Corp. | 547.66 Million USD | 99.791% |
| The Joint Corp. | 87.15 Million USD | 98.687% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 99.949% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | 85.61% |
| ModivCare Inc. | 1.76 Billion USD | 99.935% |
| NewGenIvf Group Limited | 1.64 Million USD | 30.553% |
| Option Care Health, Inc. | 3.32 Billion USD | 99.966% |
| P3 Health Partners Inc. | 860.96 Million USD | 99.867% |
| P3 Health Partners Inc. | 860.96 Million USD | 99.867% |
| The Pennant Group, Inc. | 539.69 Million USD | 99.788% |
| Surgery Partners, Inc. | 7.01 Billion USD | 99.984% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | 76.761% |
| Talkspace, Inc. | 142.22 Million USD | 99.196% |
| Talkspace, Inc. | 142.22 Million USD | 99.196% |
| The Oncology Institute, Inc. | 219.41 Million USD | 99.479% |
| The Oncology Institute, Inc. | 219.41 Million USD | 99.479% |